Literature DB >> 15722645

Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.

Yigang Wan1, Liubao Gu, Koichi Suzuki, Tamaki Karasawa, Yumiko Fujioka, Gi Dong Han, Hiroko Koike, Hiroshi Kawachi, Fujio Shimizu.   

Abstract

BACKGROUND/AIMS: Multi-glycoside from Tripterygium wilfordii Hook f. (GTW) is used for various immune and inflammatory diseases including renal diseases represented by mesangial proliferative glomerulonephritis (MsPGN) in China. However, there have been no fundamental studies on the operating mechanism of GTW on MsPGN. The aim of this study is to examine as the first step the effects of GTW on acute injurious process such as mesangial injury and proteinuria in an acute and reversible Thy.1.1 glomerulonephritis (Thy1.1GN) model and then to clarify the action mechanism of GTW at molecular level by examining its effects on various injurious factors in this model.
METHODS: Thy1.1 GN was induced in rats by a single intravenous injection with 500 microg of anti-Thy1.1 mAb 1-22-3. Daily oral administration of GTW and vehicle as a control was started from 3 days before injection of mAb to the day of sacrifice in each experiment. Fourteen rats were randomly divided into 2 groups, GTW-treated and vehicle-treated groups, and sacrificed on day 14 in experiment 1 or on day 7 in experiment 2 after induction of Thy1.1 GN. Proteinuria was determined on days 1, 3, 5, 7, 10 and 14 in experiment 1 or on 1, 3, 5 and 7 in experiment 2. From blood and kidneys taken at sacrifice, blood biochemical parameters, mesangial morphological changes, glomerular macrophage infiltration, and glomerular mRNA expression of cytokines were examined.
RESULTS: In experiment 1, proteinuria and mesangial matrix expansion were significantly attenuated by GTW treatment. In experiment 2, GTW treatment significantly ameliorated proteinuria, mesangial lesions and macrophage accumulation in glomerulus. In addition, it significantly reduced the glomerular expression of mRNA for PDGF, MCP-1 and IL-2.
CONCLUSION: GTW ameliorated not only proteinuria but also mesangial alterations in Thy1.1 GN most likely by reducing expression of injurious cytokines, indicating that GTW has suppressive effects on acute inflammatory changes in glomeruli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722645     DOI: 10.1159/000083980

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  9 in total

1.  Improved outcome of Henoch-Schonlein purpura nephritis by early intensive treatment.

Authors:  Fang Deng; Ling Lu; Qin Zhang; Bo Hu; Xun Xia
Journal:  Indian J Pediatr       Date:  2011-07-08       Impact factor: 1.967

2.  Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children.

Authors:  Yan-Jie Huang; Xiao-Qing Yang; Wen-Sheng Zhai; Xian-Qing Ren; Qing-Yin Guo; Xia Zhang; Meng Yang; Tatsuo Yamamoto; Yuan Sun; Ying Ding
Journal:  World J Pediatr       Date:  2014-11-20       Impact factor: 2.764

3.  Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats.

Authors:  Yifei Zhong; Xianwen Zhang; Xianfan Cai; Ke Wang; Yiping Chen; Yueyi Deng
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

4.  miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway.

Authors:  Dapeng Chen; Ying Li; Yan Mei; Wenjia Geng; Jurong Yang; Quan Hong; Zhe Feng; Guangyan Cai; Hanyu Zhu; Suozhu Shi; Xue-Yuan Bai; Xiangmei Chen
Journal:  Cell Mol Life Sci       Date:  2014-03-18       Impact factor: 9.261

5.  Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.

Authors:  Jingxia Zhao; Tingting Di; Yan Wang; Xin Liu; Daiying Liang; Guangzhong Zhang; Ping Li
Journal:  Int J Mol Med       Date:  2016-07-11       Impact factor: 4.101

6.  Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.

Authors:  Shun-Lai Shang; Guang-Yan Cai; Shu-Wei Duan; Ping Li; Qing-Gang Li; Xiang-Mei Chen
Journal:  BMC Nephrol       Date:  2018-07-18       Impact factor: 2.388

7.  Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis.

Authors:  Liuting Zhou; Zhenyan Ye; E Zhang; Li Chen; Yitong Hou; JuChun Lin; Fenglan Huang; Zhixiang Yuan
Journal:  Int J Nanomedicine       Date:  2022-03-30

8.  Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.

Authors:  Shanshan Liu; Xiayu Li; Heng Li; Qian Liang; Jun Chen; Jianghua Chen
Journal:  BMC Nephrol       Date:  2015-12-04       Impact factor: 2.388

9.  Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy.

Authors:  Jin-Ying Fang; Yue Yang; Zheng Zhang; Shi-Min Jiang; Tian-Yu Yu; Wen-Ge Li
Journal:  Chronic Dis Transl Med       Date:  2020-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.